Registration
LMH STRATEGIC SOLUTIONS for GLAXOSMITHKLINE LLC
Client
Income
—
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
General health industry issues and pharmaceutical issues impacting GSK.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALANNA TEMME New | Legislative Director, U.S. Representative Jon Porter |
Pharmacy PHA
General health industry issues and pharmaceutical issues impacting GSK.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALANNA TEMME New | Legislative Director, U.S. Representative Jon Porter |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| GLAXOSMITHKLINE, PLC | United Kingdom | United Kingdom | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.